From: Antimicrobial consumption in five adult intensive care units: a 33-month surveillance study
 | Medical/ surgical | Neuro-surgical | Burn | Cardio-thoracic | Step-down | Total |
---|---|---|---|---|---|---|
Number of DOTs | ||||||
 Aminoglycosides | 683 | 146 | 97 | 55 | 477 | 1458 |
 Carbapenems | 6609 | 1302 | 960 | 725 | 3161 | 12,757 |
 Cephalosporins | 1216 | 480 | 141 | 76 | 542 | 2455 |
 Fluoroquinolones | 1677 | 399 | 209 | 255 | 1169 | 3709 |
 Piperacillin/Tazobactam | 3473 | 1387 | 574 | 1018 | 1444 | 7896 |
 Vancomycin | 3438 | 944 | 518 | 539 | 1570 | 7009 |
 Tigecycline | 512 | 8 | 294 | 53 | 296 | 1163 |
 Colistin | 3002 | 642 | 840 | 183 | 1693 | 6360 |
 Caspofungin | 2322 | 183 | 167 | 146 | 924 | 3742 |
 Amphotericin B | 218 | 13 | 20 | 0 | 140 | 391 |
 Total | 23,150 | 5504 | 3820 | 3050 | 11,416 | 46,940 |
Rates per 1000 patient-days | ||||||
 Aminoglycosides | 35.7 | 20.0 | 14.4 | 7.7 | 34.4 | 26.9 |
 Carbapenems | 345.9 | 178.6 | 142.0 | 102.0 | 228.1 | 235.7 |
 Cephalosporins | 63.6 | 65.9 | 20.9 | 10.7 | 39.1 | 45.4 |
 Fluoroquinolones | 87.8 | 54.7 | 30.9 | 35.9 | 84.3 | 68.5 |
 Piperacillin/Tazobactam | 181.8 | 190.3 | 84.9 | 143.3 | 104.2 | 145.9 |
 Vancomycin | 180.0 | 129.5 | 76.6 | 75.9 | 113.3 | 129.5 |
 Tigecycline | 26.8 | 1.1 | 43.5 | 7.5 | 21.4 | 21.5 |
 Colistin | 157.1 | 88.1 | 124.3 | 25.8 | 122.2 | 117.5 |
 Caspofungin | 121.5 | 25.1 | 24.7 | 20.5 | 66.7 | 69.1 |
 Amphotericin B | 11.4 | 1.8 | 3.0 | 0.0 | 10.1 | 7.2 |
 Total | 1211.7 | 755.2 | 565.2 | 429.3 | 823.7 | 867.4 |